Sign In
PT-141 (Bremelanotide)
Supports sexual arousal and desire through central nervous system signaling in both men and women.
$190.00
PT-141 (Bremelanotide) is a peptide therapy that acts on melanocortin receptors in the brain, which play a key role in regulating sexual arousal and desire. Unlike traditional medications that primarily affect blood flow, PT-141 works through central nervous system signaling — supporting libido and sexual responsiveness in both men and women.
In physician-guided programs, PT-141 is used as part of broader sexual health and hormone optimization protocols. Therapy is individually assessed and dispensed through an FDA-regulated pharmacy.
PT-141 activates melanocortin MC3R and MC4R receptors in the hypothalamus — brain regions involved in the regulation of sexual motivation and arousal. This central mechanism distinguishes it from vascular-acting therapies, making it applicable to both male and female sexual health concerns.
Because it acts through neurological pathways rather than vascular dilation, PT-141 is particularly relevant when reduced desire or arousal is a primary concern. Dosing and timing are physician-directed based on individual response.
Who May Benefit From
PT-141 (Bremelanotide)
May be appropriate for those experiencing:
Libido Support
Acts on brain pathways involved in sexual desire and motivation.
Male & Female Applications
Studied for sexual health support in both men and women.
Sexual Wellness Programs
Used as part of comprehensive physician-guided sexual health protocols.
Arousal Signaling
Influences melanocortin receptors associated with sexual responsiveness.
Central Nervous System Mechanism
Works through neurological pathways rather than vascular dilation alone.
Hormone Optimization Adjunct
Commonly paired with hormone optimization for broader sexual health support.
Delivery
May be prescribed in the following physician-guided forms depending on patient preference and clinical evaluation.
Available delivery methods:
Subcutaneous injection
Oral dissolving tablets
Start Your Protocol
A licensed physician will review your information to determine whether this therapy is appropriate before any prescription is issued.